ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $123,000 | +15.0% | 30,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $107,000 | -1.8% | 30,000 | 0.0% | 0.01% | -7.7% |
| Q3 2021 | $109,000 | -16.8% | 30,000 | 0.0% | 0.01% | -18.8% |
| Q2 2021 | $131,000 | +6.5% | 30,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $123,000 | +2.5% | 30,000 | 0.0% | 0.02% | -5.9% |
| Q4 2020 | $120,000 | +48.1% | 30,000 | 0.0% | 0.02% | +30.8% |
| Q3 2020 | $81,000 | -1.2% | 30,000 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $82,000 | +15.5% | 30,000 | 0.0% | 0.02% | +15.4% |
| Q1 2020 | $71,000 | -49.6% | 30,000 | 0.0% | 0.01% | -35.0% |
| Q4 2019 | $141,000 | +41.0% | 30,000 | 0.0% | 0.02% | +33.3% |
| Q3 2019 | $100,000 | +1.0% | 30,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $99,000 | +7.6% | 30,000 | 0.0% | 0.02% | +7.1% |
| Q1 2019 | $92,000 | +12.2% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $82,000 | -18.8% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $101,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |